Literature DB >> 22553580

Ultrastructural pathology of corneal neovascularization after photodynamic therapy in rabbits.

Hong Chen1, Ming-Chang Zhang, Zhi Wang, Ying Zhang.   

Abstract

AIM: To investigate the ultrastructural pathogenesis of photodynamic therapy (PDT) for the experimental corneal neovascularization (CNV) by Hematoporphyrin Derivate (HPD) as photosensitizer and Argon laser as light source.
METHODS: Experimental CNV models were induced in 7 white rabbits using alkali burn. Six weeks after models establishment, animals with CNV were injected with HPD intravenously, and 48 hours after the injection, 7 eyes were irradiated with argon laser (power 800mw, wavelength 514.5nm, spot diameter 200µm, exposure time 2ms). The irradiated CNV was observed by light microscopy and scanning electron microscopy.
RESULTS: Histopathological study indicated that there was a striking decrease in the number of the CNV, vascular endothelium became degeneration and necrosis, some vessels were atrophy and attenuated, and vessels cavity were blocked by some thrombosis. No obvious abnormal histopathological findings were noted in surrounding tissues.
CONCLUSION: The high precise action on CNV and minimal damage to surrounding tissues with PDT by HPD as photosensitizer suggested that PDT might be an effective and safe modality in the treatment of CNV.

Entities:  

Keywords:  corneal neovascularization; histopathology; photodynamic therapy

Year:  2010        PMID: 22553580      PMCID: PMC3340747          DOI: 10.3980/j.issn.2222-3959.2010.04.07

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  5 in total

Review 1.  Corneal neovascularization.

Authors:  J H Chang; E E Gabison; T Kato; D T Azar
Journal:  Curr Opin Ophthalmol       Date:  2001-08       Impact factor: 3.761

2.  Fluorescein-potentiated argon laser therapy improves symptoms and appearance of corneal neovascularization.

Authors:  Y Jerold Gordon; Rupinder K Mann; Tammy S Mah; Michael B Gorin
Journal:  Cornea       Date:  2002-11       Impact factor: 2.651

3.  Immunologic graft reactions after allogenic penetrating keratoplasty.

Authors:  Jost B Jonas; Rainer M Rank; Wido M Budde
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

4.  The active metabolite of leflunomide A771726 inhibits corneal neovascularization.

Authors:  Mingchang Zhang; Nian Hao; Fang Bian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

5.  Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.

Authors:  David N Zacks; Eric Ezra; Yoshiko Terada; Norman Michaud; Edward Connolly; Evangelos S Gragoudas; Joan W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

  5 in total
  2 in total

1.  Attenuation of corneal neovascularization by topical low-molecular-weight heparin-taurocholate 7 without bleeding complication.

Authors:  Jae Yong Kim; Soo Yeon Kim; Mi Hyun Cheon; Eun-Soon Kim; In Seok Song; Myoung Joon Kim; Hungwon Tchah
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

2.  Intravitreal Bevacizumab with or without Triamcinolone for Wet Age-related Macular Degeneration: Twelve-month Results of a Prospective, Randomized Investigation.

Authors:  Qader Motarjemizadeh; Naser Samadi Aidenloo; Mohammad Abbaszadeh; Vahid Sadrinia
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.